MedTrace Logo

Citicoline, Creatine, and Omega-3 Effects in Middle Age Women

NCT01502813 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-04-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the functional effects of a citicoline, creatine, and omega-3 fatty acids combination when administered for a duration of four weeks (28 days) to non-psychiatric adult female participants.

Conditions

  • Cognitive Benefits

Interventions

DRUG

Citicoline, Omega-3 Fatty Acids and Creatine

Citicoline: 500 mg/day for 28 days Omega-3 Fatty Acids: 2 g/day for 28 days Creatine: 5 g/day for 28 days

Sponsors & Collaborators

  • Deborah Yurgelun-Todd

    lead OTHER

Principal Investigators

  • Deborah Yurgelun-Todd, PhD · The Brain Institute, University of Utah

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-01
Primary Completion
2018-10-30
Completion
2019-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01502813 on ClinicalTrials.gov